Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of intradermal versus intramuscular inactivated split-virion influenza vaccine in adults
2005-002401-23Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of influenza vaccine in influenza and seasonal influenza (2 arms), sponsored by Sanofi. Primary endpoint: Anti-HA antibody titers at Day 21 after first vaccination. Started Jun 2005; status: completed.
02
Drugs
influenza vaccine
03
Conditions
influenzaseasonal influenza
Beyond the preview
Go deeper on 2005-002401-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002401-23.